메뉴 건너뛰기




Volumn 28, Issue 10, 2010, Pages 1625-1627

Defining the clinical utility of gene expression assays in breast cancer: The intersection of science and art in clinical decision making

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

EID: 77950500673     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.25.2882     Document Type: Editorial
Times cited : (20)

References (34)
  • 1
    • 0034493155 scopus 로고    scopus 로고
    • The practice of clinical medicine as an art and as a science
    • Saunders J: The practice of clinical medicine as an art and as a science. Med Humanit 26:18-22, 2000
    • (2000) Med Humanit , vol.26 , pp. 18-22
    • Saunders, J.1
  • 2
    • 19344364880 scopus 로고    scopus 로고
    • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials
    • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet 365:1687-1717, 2005
    • (2005) Lancet , vol.365 , pp. 1687-1717
  • 4
    • 0034680102 scopus 로고    scopus 로고
    • Molecular portraits of human breast tumours
    • Perou CM, Sorlie T, Eisen MB, et al: Molecular portraits of human breast tumours. Nature 406:747-752, 2000
    • (2000) Nature , vol.406 , pp. 747-752
    • Perou, C.M.1    Sorlie, T.2    Eisen, M.B.3
  • 5
    • 0037137519 scopus 로고    scopus 로고
    • A gene-expression signature as a predictor of survival in breast cancer
    • van de Vijver MJ, He YD, van't Veer LJ, et al: A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999-2009, 2002
    • (2002) N Engl J Med , vol.347 , pp. 1999-2009
    • Van De Vijver, M.J.1    He, Y.D.2    Van't Veer, L.J.3
  • 8
    • 52049095087 scopus 로고    scopus 로고
    • A five-gene molecular grade index and HOXB13:IL17BR are complementary prognostic factors in early stage breast cancer
    • Ma XJ, Salunga R, Dahiya S, et al: A five-gene molecular grade index and HOXB13:IL17BR are complementary prognostic factors in early stage breast cancer. Clin Cancer Res 14:2601-2608, 2008
    • (2008) Clin Cancer Res , vol.14 , pp. 2601-2608
    • Ma, X.J.1    Salunga, R.2    Dahiya, S.3
  • 10
    • 77950494285 scopus 로고    scopus 로고
    • Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection
    • Lo SS, Murphy PB, Norton J, et al: Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection. J Clin Oncol 28:1671-1676, 2010
    • (2010) J Clin Oncol , vol.28 , pp. 1671-1676
    • Lo, S.S.1    Murphy, P.B.2    Norton, J.3
  • 11
    • 77950482645 scopus 로고    scopus 로고
    • Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor - Positive breast cancer: Results from NSABP B-14 and NSABP B-20
    • Mamounas EP, Tang G, Fisher B, et al: Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor - positive breast cancer: Results from NSABP B-14 and NSABP B-20. J Clin Oncol 28:1677-1683, 2010
    • (2010) J Clin Oncol , vol.28 , pp. 1677-1683
    • Mamounas, E.P.1    Tang, G.2    Fisher, B.3
  • 12
    • 39149113165 scopus 로고    scopus 로고
    • Development of the 21-gene assay and its application in clinical practice and clinical trials
    • DOI 10.1200/JCO.2007.15.1068
    • Sparano JA, Paik S: Development of the 21-gene assay and its application in clinical practice and clinical trials. J Clin Oncol 26:721-728, 2008 (Pubitemid 351264384)
    • (2008) Journal of Clinical Oncology , vol.26 , Issue.5 , pp. 721-728
    • Sparano, J.A.1    Paik, S.2
  • 13
    • 39749131644 scopus 로고    scopus 로고
    • Surviving recurrence: Psychological and quality-of-life recovery
    • DOI 10.1002/cncr.23272
    • Yang HC, Thornton LM, Shapiro CL, et al: Surviving recurrence: Psychological and quality-of-life recovery. Cancer 112:1178-1187, 2008 (Pubitemid 351304605)
    • (2008) Cancer , vol.112 , Issue.5 , pp. 1178-1187
    • Yang, H.-C.1    Thornton, L.M.2    Shapiro, C.L.3    Andersen, B.L.4
  • 14
    • 25144513383 scopus 로고    scopus 로고
    • Psychological responses to cancer recurrence
    • Andersen BL, Shapiro CL, Farrar WB, et al: Psychological responses to cancer recurrence. Cancer 104:1540-1547, 2005
    • (2005) Cancer , vol.104 , pp. 1540-1547
    • Andersen, B.L.1    Shapiro, C.L.2    Farrar, W.B.3
  • 15
    • 0025914840 scopus 로고
    • Significance of ipsilateral breast tumour recurrence after lumpectomy
    • Fisher B, Anderson S, Fisher ER, et al: Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 338:327-331, 1991
    • (1991) Lancet , vol.338 , pp. 327-331
    • Fisher, B.1    Anderson, S.2    Fisher, E.R.3
  • 16
    • 33646454600 scopus 로고    scopus 로고
    • Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five national surgical adjuvant breast and bowel project node-positive adjuvant breast cancer trials
    • DOI 10.1200/JCO.2005.04.3273
    • Wapnir IL, Anderson SJ, Mamounas EP, et al: Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol 24:2028-2037, 2006 (Pubitemid 46622111)
    • (2006) Journal of Clinical Oncology , vol.24 , Issue.13 , pp. 2028-2037
    • Wapnir, I.L.1    Anderson, S.J.2    Mamounas, E.P.3    Geyer Jr., C.E.4    Jeong, J.-H.5    Tan-Chiu, E.6    Fisher, B.7    Wolmark, N.8
  • 19
    • 66349105317 scopus 로고    scopus 로고
    • Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five national surgical adjuvant breast and bowel project protocols of node-negative breast cancer
    • Anderson SJ, Wapnir I, Dignam JJ, et al: Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five national surgical adjuvant breast and bowel project protocols of node-negative breast cancer. J Clin Oncol 27:2466-2473, 2009
    • (2009) J Clin Oncol , vol.27 , pp. 2466-2473
    • Anderson, S.J.1    Wapnir, I.2    Dignam, J.J.3
  • 21
    • 0042065358 scopus 로고    scopus 로고
    • Outcome of treatment for breast cancer patients with chest wall recurrence according to initial stage: Implications for post-mastectomy radiation therapy
    • DOI 10.1016/S0360-3016(03)00431-0
    • Chagpar A, Kuerer HM, Hunt KK, et al: Outcome of treatment for breast cancer patients with chest wall recurrence according to initial stage: Implications for post-mastectomy radiation therapy. Int J Radiat Oncol Biol Phys 57:128-135, 2003 (Pubitemid 36959748)
    • (2003) International Journal of Radiation Oncology Biology Physics , vol.57 , Issue.1 , pp. 128-135
    • Chagpar, A.1    Kuerer, H.M.2    Hunt, K.K.3    Strom, E.A.4    Buchholz, T.A.5
  • 23
    • 18744393759 scopus 로고    scopus 로고
    • Predictors of local recurrence after breast-conservation therapy
    • Horst KC, Smitt MC, Goffinet DR, et al: Predictors of local recurrence after breast-conservation therapy. Clin Breast Cancer 5:425-438, 2005
    • (2005) Clin Breast Cancer , vol.5 , pp. 425-438
    • Horst, K.C.1    Smitt, M.C.2    Goffinet, D.R.3
  • 24
    • 33845808289 scopus 로고    scopus 로고
    • Predicting a local recurrence after breast-conserving therapy by gene expression profiling
    • Nuyten DS, Kreike B, Hart AA, et al: Predicting a local recurrence after breast-conserving therapy by gene expression profiling. Breast Cancer Res 8:R62, 2006
    • (2006) Breast Cancer Res , vol.8
    • Nuyten, D.S.1    Kreike, B.2    Hart, A.A.3
  • 25
    • 33645729721 scopus 로고    scopus 로고
    • NCCN Task Force Report: Adjuvant Therapy for Breast Cancer
    • suppl 1
    • Carlson RW, Brown E, Burstein HJ, et al: NCCN Task Force Report: Adjuvant Therapy for Breast Cancer. J Natl Compr Canc Netw 4:S1-S26, 2006
    • (2006) J Natl Compr Canc Netw , vol.4
    • Carlson, R.W.1    Brown, E.2    Burstein, H.J.3
  • 26
    • 0035752610 scopus 로고    scopus 로고
    • Patient preferences for adjuvant chemotherapy of early breast cancer: How much benefit is needed?
    • Simes RJ, Coates AS: Patient preferences for adjuvant chemotherapy of early breast cancer: How much benefit is needed? J Natl Cancer Inst Monogr 30:146-152, 2001
    • (2001) J Natl Cancer Inst Monogr , vol.30 , pp. 146-152
    • Simes, R.J.1    Coates, A.S.2
  • 27
    • 33750895236 scopus 로고    scopus 로고
    • TAILORx: Trial assigning individualized options for treatment (Rx)
    • Sparano JA: TAILORx: Trial assigning individualized options for treatment (Rx). Clin Breast Cancer 7:347-350, 2006
    • (2006) Clin Breast Cancer , vol.7 , pp. 347-350
    • Sparano, J.A.1
  • 28
    • 41649089610 scopus 로고    scopus 로고
    • Options for slowing the growth of health care costs
    • Mongan JJ, Ferris TG, Lee TH: Options for slowing the growth of health care costs. N Engl J Med 358:1509-1514, 2008
    • (2008) N Engl J Med , vol.358 , pp. 1509-1514
    • Mongan, J.J.1    Ferris, T.G.2    Lee, T.H.3
  • 29
    • 67651149757 scopus 로고    scopus 로고
    • Prioritizing comparative-effectiveness research: IOM recommendations
    • Iglehart JK: Prioritizing comparative-effectiveness research: IOM recommendations. N Engl J Med 361:325-328, 2009
    • (2009) N Engl J Med , vol.361 , pp. 325-328
    • Iglehart, J.K.1
  • 30
    • 52049089470 scopus 로고    scopus 로고
    • Does Oncotype DX recurrence score effect management of patients with early stage breast cancer
    • Asad J, Jacobson AF, Estabrook A, et al: Does Oncotype DX recurrence score effect management of patients with early stage breast cancer. Am J Surg 196:527-529, 2008
    • (2008) Am J Surg , vol.196 , pp. 527-529
    • Asad, J.1    Jacobson, A.F.2    Estabrook, A.3
  • 31
    • 42649098952 scopus 로고    scopus 로고
    • Impact of a commercial reference laboratory test recurrence score on decision making in early-stage breast cancer
    • DOI 10.1200/JOP.0742001
    • Oratz R, Paul D, Cohn AL, Sedlacek SM: Impact of a commercial reference laboratory test recurrence score on decision making in early-stage breast cancer. Journal of Oncology Practice 3:182-186, 2007 (Pubitemid 351593669)
    • (2007) Journal of Oncology Practice , vol.3 , Issue.4 , pp. 182-186
    • Oratz, R.1    Paul, D.2    Cohn, A.L.3    Sedlacek, S.M.4
  • 32
    • 33947196825 scopus 로고    scopus 로고
    • Impact of a 21-gene RT-PCR assay on treatment decisions in early-stage breast cancer: An economic analysis based on prognostic and predictive validation studies
    • DOI 10.1002/cncr.22506
    • Lyman GH, Cosler LE, Kuderer NM, et al: Impact of a 21-gene RT-PCR assay on treatment decisions in early-stage breast cancer: An economic analysis based on prognostic and predictive validation studies. Cancer 109:1011-1018, 2007 (Pubitemid 46435378)
    • (2007) Cancer , vol.109 , Issue.6 , pp. 1011-1018
    • Lyman, G.H.1    Cosler, L.E.2    Kuderer, N.M.3    Hornberger, J.4
  • 33
    • 51649110952 scopus 로고    scopus 로고
    • Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features
    • Goldstein LJ, Gray R, Badve S, et al: Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features. J Clin Oncol 26:4063-4071, 2008
    • (2008) J Clin Oncol , vol.26 , pp. 4063-4071
    • Goldstein, L.J.1    Gray, R.2    Badve, S.3
  • 34
    • 51649121333 scopus 로고    scopus 로고
    • An ideal prognostic test for estrogen receptor-positive breast cancer?
    • Paik S, Tang G, Fumagalli D: An ideal prognostic test for estrogen receptor-positive breast cancer? J Clin Oncol 26:4058-4059, 2008
    • (2008) J Clin Oncol , vol.26 , pp. 4058-4059
    • Paik, S.1    Tang, G.2    Fumagalli, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.